BIODEGRADABLE VASCULAR GRAFTS

Information

  • Research Project
  • 3502399
  • ApplicationId
    3502399
  • Core Project Number
    R43HL049707
  • Full Project Number
    1R43HL049707-01
  • Serial Number
    49707
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/1993 - 31 years ago
  • Project End Date
    3/31/1994 - 30 years ago
  • Program Officer Name
  • Budget Start Date
    6/1/1993 - 31 years ago
  • Budget End Date
    3/31/1994 - 30 years ago
  • Fiscal Year
    1993
  • Support Year
    1
  • Suffix
  • Award Notice Date
    5/28/1993 - 31 years ago
Organizations

BIODEGRADABLE VASCULAR GRAFTS

The use of biodegradable polymers for vascular reconstruction has two major advantages: the elimination of chronic foreign body reaction and the regeneration of arterial tissues including a nonthrombogenic pseudointima layer. However, it is well-known that the healing of human vascular tissues is very slow thus the risk of using biodegradable vascular grafts in human beings is the premature degradation of biodegradable vascular grafts. In this proposal, we are suggesting an novel method to accelerate the regeneration of arterial tissue, particularly the formation of a thrombus-free pseudointima lining of the graft. Phase I objective is to determine the feasibility to chemically modify surface characteristics of synthetic biodegradable polymers to control their adhesion characteristics for endothelial cells. Controlling the surface character of these polymers could a) lead to a better understanding of the interactions between cells and foreign materials during wound healing and b) significantly improve the biological and chemical properties of biodegradable polymers for use as new materials for the reconstruction of injured, diseased or aged human tissues and organs. The most important impact of this proposed research is to provide the required knowledge basis for rendering synthetic biodegradable polymers to have the surface property that could selectively attract desirable cells for their subsequent attachment, growth and cellular functions.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    AST PRODUCTS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    BILLERICA
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01821
  • Organization District
    UNITED STATES